TBPMF News and Press, Tetra Bio-Pharma Inc From 10/14/21

Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™ PR Newswire OTTAWA, ON , Oct. 14, 2021 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-deri...

REDUVO™ - A Major Milestone for Tetra Bio-Pharma Inc. PR Newswire Tetra is gearing up to launch REDUVO™, its first cannabinoid-derived medicine, in Canada . REDUVO™ 5-year cumulative gross sales expected to reach $121M . The Company...

Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (SAA) Report for QIXLEEF™ PR Newswire SAA Report endorsed Tetra Bio-Pharma's proposed nonclinical development and quality programs for QIXLEEF™. SAA Report provides clarity on clinical re...

Tetra Bio-Pharma Files PCT Patent Application for Cannabis Plant Residue Canada NewsWire OTTAWA, ON , July 29, 2021 /CNW/ - Tetra Bio-Pharma Inc ("Tetra" or the Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discover...

Tetra Bio-Pharma Engages Christine Caron as Patient Partner Canada NewsWire Important step for Tetra to ensure meaningful collaboration and patient engagement in research. OTTAWA, ON , July 22, 2021 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Com...

The US cannabis market received a boost in confidence this week thanks to the announcement of a new potential legalization bill. Meanwhile, a report shows cannabis producers in Canada have been forced to get rid of over 500 tons of product due to low demand, adding to the list of st...

Tetra Bio-Pharma (TBPMF) announces that the Central Ethics Committee has approved the proposed protocol modifications allowing additional immediate release oral opioids to be used as comparators in the REBORN1 study.Expanding to three immediate release oral opioids will allow for the accelera...

Tetra Bio-Pharma Accelerates REBORN1© Trial Canada NewsWire Ethics Committee approves REBORN1© protocol amendment allowing for the addition of two immediate release oral opioids to be compared against QIXLEEF™. REBORN1© is the first of its kin...

A financial analyst has issued a new report full of excitement about the US cannabis marketplace and its current players. Also this week, a Canadian exchange-traded fund (ETF) operator completed its quarterly rebalancing of two cannabis funds, meaning new names were added. Keep ...

Tetra Bio-Pharma Announces Change in Management Canada NewsWire OTTAWA, ON , June 25, 2021 /CNW/ - Tetra Bio-Pharma Inc. ( " Tetra " or the " Company " ) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a le...